Clinical Trial

Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea

Name: Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea — clinical trial record (NCT05247112)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2022-02-08.

Trial Details

NCT Number	NCT05247112
Lead Sponsor	Seoul National University Bundang Hospital
Conditions	Helicobacter Pylori Infection, Helicobacter Pylori Associated Gastrointestinal Disease, Helicobacter Pylori Infection, Susceptibility to, Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
Enrollment	2,000 participants
Start Date	2003-07-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-04-13